A real-world clinical study of camrelizumab in the treatment of esophageal cancer.

被引：0
|
作者：
Sun, Guoping
Qian, Dong
Zhao, Dong
Liang, Hui
Cheng, Huaidong
Wang, Genhe
Wang, Fan
Jiang, Hao
Xu, Tengyun
Wu, Qibing
Zhu, Shaojin
Xu, Dong
机构：
[1] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China
[3] Lixin Cty Peoples Hosp, Lixin, Peoples R China
[4] Tradit Chinese Hosp Luan, Luan, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China
[6] Huangshan City Peoples Hosp, Huangshan, Peoples R China
[7] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[8] USTC, Dept Oncol, Affiliated Hosp 1, Hefei, Peoples R China
[9] Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China
[10] Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16008
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [1] A real-world clinical study of camrelizumab in the treatment of esophageal cancer
    Sun, G.
    Peng, W.
    Wang, F.
    Cheng, H.
    Wang, S. Z.
    Xia, L.
    Du, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1318 - S1318
  • [2] A real-world study of camrelizumab in the treatment of advanced lung cancer patients.
    Gu, Kangsheng
    Bi, Minghong
    Zhao, Dong
    Cheng, Huaidong
    Wang, Genhe
    Qian, Hong
    Min, Xuhong
    Xia, Xiaoyang
    Wang, Fan
    Hu, Zhiqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] A real-world study of camrelizumab in the treatment of hepatocellular carcinoma.
    Zeng, Yong-Yi
    Guo, Wu-hua
    Zhang, Zhibo
    Shi, Xi
    Su, Yongjie
    Cai, Qinghe
    Peng, Jianyang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Real-world clinical effectiveness and safety of camrelizumab in esophageal squamous cell carcinoma.
    Yao, Qiwei
    Fu, Zhichao
    Chen, Qisong
    Huang, Jianli
    Wu, Jintong
    Ke, Chunlin
    Ma, Liangyun
    Li, Shouguo
    He, Rongqi
    Lin, Yuyi
    Li, Jiancheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] PRELIMINARY ANALYSIS OF A REAL-WORLD STUDY (RWS) OF CAMRELIZUMAB TREATMENT IN PRIMARY LIVER CANCER (PLC)
    Chen, Zhendong
    Wang, Nianfei
    Luo, Dayong
    Jiang, Bo
    Yuan, Mu
    Li, Xinzhong
    Yao, Chunmei
    Qian, Hong
    Kan, Qingsheng
    Wang, Erxuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A479 - A480
  • [6] Real-world treatment attrition rates in advanced esophagogastric cancer.
    Tsang, Erica S.
    Lim, Howard John
    Renouf, Daniel John
    Davies, Janine Marie
    Loree, Jonathan M.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma
    Tingting Li
    Yaqing Dai
    Xiaobin Fu
    Qunrong Cai
    Dongmei Ke
    Qiwei Yao
    Jiancheng Li
    BMC Cancer, 24 (1)
  • [8] Update on long term outcome of a multicentre, prospective, real-world study of camrelizumab in the treatment of patients with advanced lung cancer
    Shu, Y.
    Wang, R.
    Ji, M.
    Shi, M.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S51 - S52
  • [9] Camrelizumab combined with apatinib in the treatment of patients with hepatocellular carcinoma: a real-world assessment
    Chen, Dongbo
    Chen, Xiangxun
    Xu, Lei
    Wang, Yichun
    Zhu, Liyang
    Kang, Mei
    NEOPLASMA, 2023, 70 (04) : 580 - 587
  • [10] Real-world effectiveness and safety of camrelizumab-based neoadjuvant therapy in resectable esophageal cancer: Initial results of a prospective multicenter observational study
    Zhang, Yi
    Shen, Guoyi
    Xu, Rongyu
    Huang, Guozhong
    Yang, Shengsheng
    Zheng, Qingfeng
    Huang, Zhijun
    Duan, Hongbing
    Ma, Liangyun
    Yang, Libao
    Yi, Yunfeng
    Liu, Rongxing
    Li, Kezhi
    Chen, Shaogeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345